Antioxidant therapy, oxidative stress and antioxidant products: Challenges and opportunities;Terapia antioxidante, estrés oxidativo y productos antioxidantes: Retos y oportunidades

Revista Cubana de Salud Publica

Volumn 37, Issue SUPPL. 5, 2011, Pages 644-660

  Sellés, Alberto J Núñez ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82055184802     PISSN: 08643466     EISSN: 15613127     Source Type: Journal    
DOI: None     Document Type: Article

References (102)

1. Renaud S, De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339:1523-6.
2. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 1995;91:1182-8.
3. Lotito SB, Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free RadicBiol Med. 2006;41:1727-46.
4. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low density lipoproteins by phenolic substances in red wine. Lancet. 1993;341:454-7.
5. Fuhrman B, Lavy A, Aviram M. Consumption of red wine and meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr. 1995;61:549-54.
6. Cutler RG. Antioxidants and aging. Am J ClinNutr. 1991;53:373S-9S.
7. Pitot HC, Dragan YP. Facts and theories concerning the mechanisms of carcinogenesis. FASEB J. 1991;5:2280-6.
8. Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol. 1993;23:21-48.
9. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res. 1996;25:57-94.
10. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med. 1995;155:381-6.
11. Elejalde Guerra JI. Oxidative stress, diseases and antioxidant treatment. An Med Interna (Madrid). 2001;18:50-9.
12. Scandalios JG. The molecular biology of free radical scavenging systems., Clairview, NY: Cold SpringHarbor Press;1992.
13. Mohanakumar KP, Thomas B. Nitric oxide: an antioxidant and neuroprotector. Ann NY Acad Sci. 2002;962:389-401.
14. Spatz L, Bloom AD, editors. Biological consequences of oxidative stress. Implications for cardiovascular disease and carcinogenesis. Massachusets: Conte Inst Environm Health; 1992.
15. Young IS, Woodside JV. Antioxidants in health and disease. ClinPathol. 2001;54:174-86.
16. Barry EM, Kohen R. Is the biological antioxidant system integrated and regulated? Exptl Physiol. 1997;82:291-5.
17. Ahmad S, editor. Oxidative stress and antioxidant defenses in Biology. Boston: Kluwer Acad Publ; 1995.
18. Forman HJ, Cadenas E, editors Oxidative stress and signal transduction. Boston: Kluwer Acad Publ; 1997.
19. Montagnier L, Oliviewr R, Pasquier C, editors. Oxidative stress in cancer, AIDS and neuro degenerative diseases. New York: M. Dekker; 1998.
20. Kumpulainen JT, Salonen JT, editors. Natural antioxidants and anticarcinogenesis in Nutrition, Health and Diseases. New York: CHIPS; 1999.
21. Oldham KM, Braun PE. Oxidative stress in critical care: Its antioxidant supplementation beneficial? J Am Diet Assoc. 1998;98:1001-8.
22. Cross JV, Templeton DJ. Regulation of signal transduction through protein cysteineoxidation. Antiox Redox Signal. 2006;8:1819-27.
23. Beck MA. Nutriitional-induced oxidative stress. Effect on viral disease. Am J Clin Nutr. 2000;72:1082-6.
24. Lorgeril M, Richard MJ. Increased production of reactive oxygen species in pharmacologically-immunosuppresed patients. Chem Biol Interact. 1994;91:159-64.
25. Clarkson PM. Antioxidantsd and physical performance. Crit Rev Food Sci Nutr. 1995;35:131-41.
26. Murray MT. Encyclopedia of Nutritional Supplements. California: Prima Pub; 1996.
27. Whitton PS. Inflammation as a causative factor in the aetiology of Parkinson ́s disease. Br J Pharmacol. 2007;150:963-76.
28. Cadenas E, Packer L, editors. Handbook of Antioxidants. New York: M. Dekker Inc;1996.
29. Combs CF, Gray WP. Chemopreventive agents: selenium. Pharmacol Ther. 1998;79:179-92.
30. Bray T, Scoene N, editors. Models and methods in cell signalling and gene expression. Application to oxidative stress research. London: OICA Interntl; 2000.
31. El-Bayoumy K, Upadhyaya P, Chae YH, Sohn OS, Rao CV, Fiala E, Reddy BS. Chemoprevention of cancer by organo selenium compounds. J Cell Biochem.1995;22 (Suppl):92-100.
32. Patrick L. Selenium biochemistry and cancer: A review of the literature. Alt Med Rev. 2004;9:239-58.
33. Baum MK, Shor-Posner G, Lai S, Zhang G, Lai H, Fletcher MA, Sauberlich H, Page B. High risk of HIV-related mortality is associated with selenium defficiency. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:370-4.
34. Yamaguchi T, Sano K, Takahura K, Saito L, Shinohara T, Asano T, Yasukura M; Ebselen study group. Ebselen in acute ischemic stroke: A placebo-controlled, double-blind, clinical trial. Stroke. 1998;29:12-7.
35. Ogana A, Yoshimoto T, Kikuchi H, Sano K, Saito I, Yamaguchi T, Yasuhara H. Ebselenin acute middle cerebral artery occlusions: A placebo-controlled, double-blind, controlled trial. Cerebrovasc Dis. 1999;9:112-8.
36. Peretz A, Siderova V, Neve J. Selenium supplementation in rheumatoid arthritis investigated in a double-blind placebo-controlled trial. Scand J Rheumatol. 2001;30:208-12.
37. Gazdik F, Kabrabova J, Gazdikova K. Decreased consumption of corticosteroids alters selenium supplementation in corticoid-dependent asthmatics. Bratisl Lek Listy. 2002;103:22-5.
38. Hawkes WC, Turek PJ. Effects of dietary selenium on sperm motility in healthy men. Androl. 2001;22:764-72.
39. Karaküçük S, ErtugrulMirza G, FarukEkinciler O, Saraymen R, Karaküçük I, Ustdal M.Selenium concentrations in serum, lens and aqueous humor of patients with senile cataracts. ActaOphthalmol Scand. 1995;73:329-32.
40. Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition. 2001;17:888-95.
41. Henriksen EJ. Exercise training and the antioxidant alpha lipoic acid in the treatment of insulin resistance and type 2 diabetes. Free Rad Biol Med. 2006;40:3-12.
42. Sachse G, Willms B. Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy. En: Gries FA, editor. Aspects of Autonomic Neuropathy in Diabetes. Stuttgart: ThiemeVerlag; 1980. p. 105-8.
43. Dworkin BM, Wormser GP, Axelrod F, Pierre N, Schwarz E, Schwartz E, Seaton T. Dietary intake in patients with acquired immunodeficiency syndrome (AIDS), patientswith AIDS-related complex, and serologically positive human immunodeficiency viruspatients: correlations with nutritional status. J Parenter Enteral Nutr. 1990;14:605-9.
44. Fuchs J, Schöfer H, Milbradt R, Freisleben HJ, Buhl R, Siems W, Grune T. Studies on lipoate effects on blood redox state in human immunodeficiency virus infected patients. Arzneimittelforschung. 1993;43:1359-62.
45. Berkson BM. A conservative triple antioxidant approach to the treatment of hepatitis C. Med Klin. 1999;94:84-9.
46. Maitra I, Serbinova E, Trischler H, Packer L. Alpha lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats. Free Rad Biol Med. 1995;18:823-9.
47. Stoll S, Hartmann H, Cohen SA, Müller WE. The potent free radical scavenger alphalipoic acid improves memory in aged mice: putative relationship to NMDA receptor deficits. Pharmacol Biochem Behav. 1993;46:799-805.
48. Thomas SR, Stocker R. Molecular action of vitamin E in lipoprotein oxidation: Implications for atherosclerosis. Free Rad Biol Med. 2000;28:1795-2005.
49. Steinberg D. Antioxidant vitamins and coronary heart disease. N Engl J Med. 1993;328:1487-9.
50. Gey KF, Stähelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel prospective study. Clin Investig. 1993;71:3-6.
51. Sies H. Oxidative stress: oxidants and antioxidants. Exptl Physiol. 1997;82:291-5.
52. Juranek I, Bezek S. Controversy of free radical hypothesis: reactive oxygen species-causeor consequence of tissue injury? Gen Physiol Biophys. 2005;24:263-78.
53. Agudo A, Cabrera L, Amiano P, Ardanaz E, Barricarte A, Berenguer T, et al. Fruit and vegetable intakes, dietary antioxidant nutrients, and total mortality in Spanish adults: findings from the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain). Am J ClinNutr.2007;85:1634-42.
54. Miller NJ, Johnston JD, Collis CS, Rice-Evans C. Serum total antioxidant activity after myocardial infarction. Ann Clin Biochem. 1997;34:85-90.
55. O'Brien SF, Watts GF, Powrie JK, Shaw KM, Miller NJ. Lipids, lypoproteins, antioxidants and glomerular and tubular dysfunction in type I diabetes. Diabetes Res Clin Pract. 1996;32:81-90.
56. Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G, Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis. 1994;53:51-3.
57. Sharma RK, Agarwal A. Role of reactive oxygen species in male infertility. Urology.1996;48:835-50.
58. Ebadi M, Srinivasan SK, Baxi MD. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog Neurobiol. 1996;48:1-19.
59. Portal BC, Richard MJ, Faure HS, Hadjian AJ, Favier AE. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr. 1995;61:843-7.
60. Rozzilli P, Visalli N, Signore A, Baroni MG, Buzzeti R, Cavballo MG, et al. Double-blind trial of nicotinamide in recent-onset IDDM. Diabetologia. 1995;38:848-52.
61. Heller B, Burkart V, Lampeter E, Kolb H. Antioxidant therapy for the prevention of type I diabetes. Adv Pharmacol. 1997;38:629-38.
62. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet. 2003;361:2017-23.
63. Sowers JR. Hypertension, angiotensin II and oxidative stress. N Engl J Med. 2002;346:199-201.
64. Nakamura H, Nakamura K, Yodai J. Redox regulation of cellular activation. Ann RevImmunol. 1997;15:351-69.
65. Nakamura H, Nakamura K, Yodai J. Redox regulation of cellular activation. Ann Rev Immunol. 1997;15:351-69.
66. Cutter RC, Rodríguez H, editors. Critical reviews of oxidative stress and aging. Vol. I, II. London: World Scientific; 2002.
67. Sayre LM, Smith MA, Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem. 2001;8:721-38.
68. Schulz JB, Lindenau J, Seyfried J, Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem. 2000;267:4904-11.
69. Pratico D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ. Increase of brain oxidative stress in mild cognitive impairment. A possible predictor of Alzheimer disease. Arch Neurol. 2002;59:972-6.
70. Klein JA, Longo CM, Rossman MP, Seburn L, Hurd RE, Frankel WN, et al. The harlequin mouse mutation down regulates apoptosis-inducing factor. Nature. 2002;419:367-74.
71. Boldyrev AA. Discrimination between apoptosis and necrosis of neurons under oxidative stress. Biochemistry (Mosc). 2000;65:834-42.
72. Rahman I, Tomasi A. 2nd International Meeting on Free Radicals in Health and Disease.The role of oxidants and antioxidants in the regulation of chronic diseases, may 8-12,2002, Istanbul, Turkey. Free Radic Res. 2003;37:349-54.
73. Morel Y, Barouki R. Repression of gene expression by oxidative stress. Biochem J. 1999;342:481-96.
74. Benzie IFF, Strain JJ. Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurements of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299:15-27.
75. Esterbauer H. Estimation of peroxidative damage. A critical review. Pathol Biol. 1996;44:25-8.
76. Albertini R, Abuja PM. Monitoring of low density lipoprotein oxidation by lowlevel chemiluminescence. Free Radic Res. 1998;29:75-83.
77. Biaglow JE, Manevich Y, Uckum F, Held KD. Quantitation of hydroxyl radicals produced by radiation and copper-linked oxidation of ascorbate by 2-deoxy-D- ribosemethod. Free Radic Biol Med. 1997;22:1129-38.
78. Halliwell B, Kaur H. Hydroxylation of salicylate and phenylalanine as assays for hydroxyl radicals: A cautionary note visited for the third time. Free Radic Res. 1997;7:239-44.
79. Zhang Y, Chen SY, Hsu T, Santella RM. Immunohistochemical detection of malondialdehyde-DNA adducts in human oral mucosa cells. Carcinogenesis. 2002;23:207-11.
80. Halliwell B, Gutteridge JM. Free Radicals in Biology and Medicine, third edition. Midsomer Norton, Avon, England: Oxford University Press; 1999.
81. Amano F, Noda T. Improved detection of nitric oxide radical (NO) production in an activated macrophage culture with a radical scavenger, carboxy PTIO and Griessreagent. FEBS Lett. 1995;368:25-8.
82. Sutherland JC, Monteleone DC, Trunk JG, Bennett PV, Sutherland BM. Quantifying DNA damage by gel electrophoresis, electronic imaging and numberaverage lengthanalysis. Electrophoresis. 2001;22:843-54.
83. Levine RL, Wehr N, Wikkiams JA, Stadtman ER, Shacter E. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol. 2000;99:15-24.
84. Kutham H, Ullrich V, Estabrook RW. A quantitative test for superoxide radicals produced in biological systems. Biochem J. 1982;203:551-8.
85. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta. 2003;333:19-39.
86. Motchnik PA, Frei B, Ames BN. Measurment of antioxidants in human blood plasma. Methods Enzymol. 1994;234:269-79.
87. Shishehbor MH, Hazen SL. Antioxidant studies need a change of direction. Clev J Clin Med. 2004;71(4):285-8.
88. Gey KF. Free radicals in the environment, medicine and toxicology. En: Cody B, Middleton E, Harborne JB,editors. New York: A.R. Liss; 1994. p. 15-24.
89. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol. 2002;30:620-50.
90. Galati G, O'Brien PJ. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med. 2004;37:287-303.
91. Zamora ZB, Borrego A, López OY, Delgado R, González R, Menéndez S, Hernández Schulz S. Effects of ozone oxidative preconditioning on TNFá release and antioxidant prooxidant intracellular balance in mice during endotoxic shock. Med Inflamm. 2005;16-22.
92. Hasnian BJ, Mooradian AD. Recent trials of antioxidant therapy: What should we be telling our patients? Clev Clin J Med. 2004;71(4):327-4.
93. Gilgun Sherki Y, Rozenbaum Z, Relamed E, Offen D. Antioxidant therapy in Acute Central NervousSystem Injury: Current State. Pharmacol Rev. 2002;54:271-84.
94. Dandrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoide. Cancer J Clin. 2005;55:319-21.
95. Prasad KN, Cole WC. Antioxidants in chemotherapy. J Clin Oncol. 2006;24(6):8-9.
96. Agarwal A, Saleh A. Utility of oxidative stress in the male infertility clinic. Natl J Androl. 2002;8:1-9.
97. McAlindon TE, Biggee BA. Nutritional factors and osteoarthritis: recent developments. Curr Opin Rheumatol. 2005;17:647-52.
98. Pasqualotto FF, Sharma RK, Potts JM, Nelson DR, Thomas AJ, Agarwal A. Seminal oxidative stress in patients with chronic prostatitis. Urology. 2000;55:881-5.
99. Manzella D, Barbieri M, Ragno E, Paolisso G. Chronic administration of pharmacological doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes. Am J ClinNutr. 2001;73:1052-7.
100. Vertugno M, Maino A, Cardia G, Quaranta MG, Cardia L. A randomised, double masked, clinical trial of a high dose of vitamin A and vitamin E supplementation after photorefractive keratectomy. Br J Ophthalmol. 2001;85:537-9.
101. Núñez Sellés AJ. Antioxidants theraphy: Myth or reality? J Braz Chem Soc. 2005;16:699-710.
102. Bjelakovic G, Nikolova D, Lotte-Gluud L, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. JAMA. 2007;297:842-57.